EA200400501A1 - Способ снижения заболеваемости и смертности, связанных с критическими состояниями - Google Patents
Способ снижения заболеваемости и смертности, связанных с критическими состояниямиInfo
- Publication number
- EA200400501A1 EA200400501A1 EA200400501A EA200400501A EA200400501A1 EA 200400501 A1 EA200400501 A1 EA 200400501A1 EA 200400501 A EA200400501 A EA 200400501A EA 200400501 A EA200400501 A EA 200400501A EA 200400501 A1 EA200400501 A1 EA 200400501A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- reduce
- critical conditions
- disease
- mortality associated
- mortality
- Prior art date
Links
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 108010088406 Glucagon-Like Peptides Proteins 0.000 abstract 2
- 206010038687 Respiratory distress Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/26—Glucagons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Endocrinology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US32633001P | 2001-10-01 | 2001-10-01 | |
PCT/US2002/028123 WO2003028626A2 (en) | 2001-10-01 | 2002-09-19 | Glucagon-like peptides (glp-1) and treatment of respiratory distress |
Publications (1)
Publication Number | Publication Date |
---|---|
EA200400501A1 true EA200400501A1 (ru) | 2005-06-30 |
Family
ID=23271764
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA200400501A EA200400501A1 (ru) | 2001-10-01 | 2002-09-19 | Способ снижения заболеваемости и смертности, связанных с критическими состояниями |
Country Status (19)
Country | Link |
---|---|
US (2) | US20040235726A1 (cs) |
EP (1) | EP1443952A4 (cs) |
JP (1) | JP2005523877A (cs) |
KR (1) | KR20040040482A (cs) |
CN (1) | CN1561224A (cs) |
BR (1) | BR0212620A (cs) |
CA (1) | CA2462543A1 (cs) |
CZ (1) | CZ2004441A3 (cs) |
EA (1) | EA200400501A1 (cs) |
EC (1) | ECSP045044A (cs) |
HR (1) | HRP20040258A2 (cs) |
HU (1) | HUP0600437A2 (cs) |
IL (1) | IL160631A0 (cs) |
MX (1) | MXPA04002996A (cs) |
NO (1) | NO20041351L (cs) |
PL (1) | PL373846A1 (cs) |
SK (1) | SK1432004A3 (cs) |
WO (1) | WO2003028626A2 (cs) |
ZA (1) | ZA200402557B (cs) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2003532691A (ja) | 2000-05-05 | 2003-11-05 | ノボ ノルディスク アクティーゼルスカブ | 重症疾患神経障害 |
US20030199445A1 (en) | 2002-02-07 | 2003-10-23 | Knudsen Lotte Bjerre | Use of GLP-1 compound for treatment of critically ill patients |
AU2003203146A1 (en) * | 2002-02-07 | 2003-09-02 | Novo Nordisk A/S | Use of glp-1 compound for treatment of critically ill patients |
WO2003072143A1 (en) * | 2002-02-27 | 2003-09-04 | Pharmain, Ltd. | Compositions for delivery of therapeutics and other materials, and methods of making and using the same |
US20050260259A1 (en) * | 2004-04-23 | 2005-11-24 | Bolotin Elijah M | Compositions for treatment with glucagon-like peptide, and methods of making and using the same |
US7635463B2 (en) | 2002-02-27 | 2009-12-22 | Pharmain Corporation | Compositions for delivery of therapeutics and other materials |
CA2551039C (en) | 2003-12-16 | 2013-01-29 | Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R | Analogues of glp-1 |
TWI364292B (en) | 2005-06-30 | 2012-05-21 | Ipsen Pharma Sas | Glp-1 pharmaceutical compositions |
AU2006330610B2 (en) | 2005-12-19 | 2012-08-16 | Pharmain Corporation | Hydrophobic core carrier compositions for delivery of therapeutic agents, methods of making and using the same |
MX2008013304A (es) | 2006-04-20 | 2008-10-27 | Amgen Inc | Compuestos de peptido 1 tipo glucagon. |
JP2010043001A (ja) * | 2006-11-09 | 2010-02-25 | Sanwa Kagaku Kenkyusho Co Ltd | Glp−1誘導体とその用途 |
US7960336B2 (en) | 2007-08-03 | 2011-06-14 | Pharmain Corporation | Composition for long-acting peptide analogs |
US8563527B2 (en) | 2007-08-20 | 2013-10-22 | Pharmain Corporation | Oligonucleotide core carrier compositions for delivery of nucleic acid-containing therapeutic agents, methods of making and using the same |
US20090176892A1 (en) | 2008-01-09 | 2009-07-09 | Pharmain Corporation | Soluble Hydrophobic Core Carrier Compositions for Delivery of Therapeutic Agents, Methods of Making and Using the Same |
EP2340049B1 (en) | 2008-09-12 | 2015-11-11 | Novo Nordisk A/S | Method of acylating a peptide or protein |
WO2010054326A2 (en) | 2008-11-07 | 2010-05-14 | The General Hospital Corporation | C-terminal fragments of glucagon-like peptide-1 (glp-1) |
EP2216042A1 (en) | 2009-02-09 | 2010-08-11 | Ipsen Pharma S.A.S. | GLP-1 analogues pharmaceutical compositions |
DE102009024229B3 (de) * | 2009-06-08 | 2010-10-14 | Salzsieder, Eckhard, Dipl.-Phys., Dr. rer.nat. | Indikationseinrichtung zur automatisierten Bestimmung des individuellen Inkretin-Sensitivitäts-Indexes eines Probanden |
JP2013530993A (ja) | 2010-07-02 | 2013-08-01 | アンジオケム インコーポレーテッド | 治療用コンジュゲートのための短く且つd−アミノ酸を含有するポリペプチドおよびその使用 |
US9040481B2 (en) | 2010-11-02 | 2015-05-26 | The General Hospital Corporation | Methods for treating steatotic disease |
EP2729157B1 (en) | 2011-07-06 | 2019-01-16 | The General Hospital Corporation | A pentapeptide derived from the c-terminus of glucagon-like peptide 1 (glp-1) for use in treatment |
ES2810153T3 (es) * | 2012-03-01 | 2021-03-08 | Novo Nordisk As | Profármacos de GLP-1 |
US20230218556A1 (en) * | 2020-05-01 | 2023-07-13 | Irazu Bio | Method for treating respiratory viral infections comprising administration of fatty acid compositions |
CN116847868A (zh) * | 2021-01-29 | 2023-10-03 | 韩美药品株式会社 | 用于预防或治疗肺部疾病的包括gip衍生物或其长效共轭物的药学组合物 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6006753A (en) * | 1996-08-30 | 1999-12-28 | Eli Lilly And Company | Use of GLP-1 or analogs to abolish catabolic changes after surgery |
US6277819B1 (en) * | 1996-08-30 | 2001-08-21 | Eli Lilly And Company | Use of GLP-1 or analogs in treatment of myocardial infarction |
MY155270A (en) * | 1998-09-24 | 2015-09-30 | Lilly Co Eli | Use of glp-1 or analogs in treatment of stroke |
US6271241B1 (en) * | 1999-04-02 | 2001-08-07 | Neurogen Corporation | Cycloalkyl and aryl fused aminoalkyl-imidazole derivatives: modulators and GLP-1 receptors |
-
2002
- 2002-09-19 SK SK143-2004A patent/SK1432004A3/sk not_active Application Discontinuation
- 2002-09-19 BR BR0212620-6A patent/BR0212620A/pt not_active IP Right Cessation
- 2002-09-19 EP EP02761559A patent/EP1443952A4/en not_active Withdrawn
- 2002-09-19 CZ CZ2004441A patent/CZ2004441A3/cs unknown
- 2002-09-19 IL IL16063102A patent/IL160631A0/xx unknown
- 2002-09-19 CN CNA028194535A patent/CN1561224A/zh active Pending
- 2002-09-19 EA EA200400501A patent/EA200400501A1/ru unknown
- 2002-09-19 JP JP2003531963A patent/JP2005523877A/ja active Pending
- 2002-09-19 WO PCT/US2002/028123 patent/WO2003028626A2/en active Application Filing
- 2002-09-19 US US10/488,670 patent/US20040235726A1/en not_active Abandoned
- 2002-09-19 CA CA002462543A patent/CA2462543A1/en not_active Abandoned
- 2002-09-19 KR KR10-2004-7004767A patent/KR20040040482A/ko not_active Application Discontinuation
- 2002-09-19 HU HU0600437A patent/HUP0600437A2/hu unknown
- 2002-09-19 MX MXPA04002996A patent/MXPA04002996A/es not_active Application Discontinuation
- 2002-09-19 PL PL02373846A patent/PL373846A1/xx not_active Application Discontinuation
-
2004
- 2004-03-17 HR HRP20040258 patent/HRP20040258A2/xx not_active Application Discontinuation
- 2004-03-31 NO NO20041351A patent/NO20041351L/no unknown
- 2004-03-31 ZA ZA200402557A patent/ZA200402557B/xx unknown
- 2004-04-01 EC EC2004005044A patent/ECSP045044A/es unknown
-
2007
- 2007-08-22 US US11/842,967 patent/US20080032932A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2003028626A2 (en) | 2003-04-10 |
CA2462543A1 (en) | 2003-04-10 |
PL373846A1 (en) | 2005-09-19 |
BR0212620A (pt) | 2005-09-20 |
CN1561224A (zh) | 2005-01-05 |
NO20041351D0 (no) | 2004-03-31 |
EP1443952A4 (en) | 2005-09-07 |
ECSP045044A (es) | 2004-04-28 |
WO2003028626A3 (en) | 2003-10-09 |
MXPA04002996A (es) | 2004-07-15 |
US20080032932A1 (en) | 2008-02-07 |
CZ2004441A3 (cs) | 2004-11-10 |
KR20040040482A (ko) | 2004-05-12 |
HUP0600437A2 (en) | 2006-09-28 |
SK1432004A3 (sk) | 2005-03-04 |
US20040235726A1 (en) | 2004-11-25 |
EP1443952A2 (en) | 2004-08-11 |
ZA200402557B (en) | 2005-05-09 |
HRP20040258A2 (en) | 2004-12-31 |
NO20041351L (no) | 2004-06-30 |
IL160631A0 (en) | 2004-07-25 |
JP2005523877A (ja) | 2005-08-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA200400501A1 (ru) | Способ снижения заболеваемости и смертности, связанных с критическими состояниями | |
EA200300644A1 (ru) | Слитые белки glp-1 | |
HRP20020996B1 (en) | Glucagon-like peptide-1 analogs | |
TW200626613A (en) | Analogues of GLP-1 | |
DK1137666T3 (da) | GLP-1-analoger | |
EA200100289A1 (ru) | Способ введения инсулинотропных пептидов | |
ATE536881T1 (de) | Glp-1, exendin-4, peptid-analoga und verwendungen davon | |
EA200001037A1 (ru) | Легочная и назальная доставка ралоксифена | |
EA200300873A1 (ru) | Новая соль сукцинат o-десметилвенлафаксина | |
EA200300459A1 (ru) | Новые, применяемые в качестве медикаментов антихолинергические средства, а также способ их получения | |
AU7485301A (en) | Methods for refolding proteins containing free cysteine residues | |
EA200300527A1 (ru) | Новые способы лечения синдрома "усталых ног" | |
EA200301223A1 (ru) | Лекарственные формы окскарбазепина | |
DK1349578T3 (da) | Kombinationspræparat indeholdende en biguanin (metformin) og arginin | |
ATE403726T1 (de) | Cytokin-proteinfamilie | |
ATE481420T1 (de) | Il-21-derivate | |
DE60332425D1 (de) | 5t4-antigen-peptidepitope der mhc klasse ii | |
EA200201232A1 (ru) | Производные сульфонамида | |
EA200201234A1 (ru) | Производные сульфонамида | |
SE0201938D0 (sv) | New process | |
ATE374811T1 (de) | Hühner-astrovirus typ 2 | |
ES2163142T3 (es) | Nuevos peptidos y agente neotropico. | |
TH51594A (th) | สารประกอบเปปไทด์-1 แอนาลอกคล้ายกับกลูคากอน | |
DE69942305D1 (de) | Derivate von glp-1 und exendin mit verlängertem wirkdauer-profil | |
ECSP993116A (es) | Procedimiento para administrar peptidos insulinotropicos |